Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cerebellar Purkinje cells are a class of large GABAergic neurons located in the cerebellum and are characterized by their elaborate dendritic arborization. They serve as the primary integration center and the sole inhibitory output of the cerebellar cortex, playing a fundamental role in motor control, coordination, and precision (StatPearls, 2023). These cells receive excitatory inputs from parallel fibers and climbing fibers, which they process to regulate motor learning and timing (NIH, 2022). Degeneration or loss of Purkinje cells is a central feature in many neurodegenerative diseases, including spinocerebellar ataxias (SCAs) and gluten ataxia (PubMed, 2021). Although the cell itself is not a single molecular target, its specific ion channels (such as P/Q-type calcium channels) and receptors (such as mGluR1) are major sites for pharmacological intervention in movement disorders (UniProt, 2023). Drugs like riluzole are often investigated for their ability to modulate the excitability of these neurons to alleviate symptoms of cerebellar dysfunction (PubMed, 2020).
Pharmacological agents typically modulate Purkinje cell activity by targeting their specific voltage-gated ion channels (e.g., P/Q-type calcium channels) or GABAergic and glutamatergic receptors to stabilize firing rates and restore inhibitory output to the deep cerebellar nuclei.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cerebellar Purkinje cell (PC).